Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

On 3rd September, the 30-share BSE Sensex slipped 4.40 points or 0.01 per cent to settle at 82,555.44 in a range-bound trade. During the day, it dropped 159.08 points or 0.19 per cent to 82,400.76 ...

Merck faces significant challenges, including increased competition and regulatory scrutiny for Keytruda. Keytruda is facing potential threats from competitors like Summit Therapeutics ...

State-owned Container Corporation of India Ltd (Concor) is soon starting coastal movement of goods as part of its multi-modal logistics strategy to offer a cheap, fast, and cleaner mode of ...

It is hard to get excited after looking at Merck's (NYSE:MRK) recent performance, when its stock has declined 5.6% over the past three months. But if you pay close attention, you might find that ...

A Reddit thread started Thursday titled, "What's wrong with the Facebook logo?" shows a blue lowercase "f" on a black background instead of a blue background with a white "f." Some users who have ...

A Merck & Co. effort to move its PD-1 behemoth Keytruda into early treatment of lung cancer has reached a dead end, along with another bid to expand into a type of early-stage skin cancer.

RAHWAY, N.J., August 29, 2024--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided updates on two Phase 3 trials, KEYNOTE-867 and KEYNOTE-630.

Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab Clinical ...

In a report released today, Louise Chen from Cantor Fitzgerald maintained a Buy rating on Merck & Company (MRK – Research Report), with a price target of $155.00. The company’s shares closed ...

As an established mining contractor, Concor Mining Services actively builds the sector’s skills base through training and mentoring. Photo: Supplied Through its continuous investment in formalised ...

(RTTNews) - Merck & Co Inc. (MRK), Monday said it received approval from the European Commission for Winrevair in combination with other pulmonary arterial hypertension (PAH) therapies, for the ...